Our colleague and NIHR Leeds BRC member Professor Francesco Del Galdo recently achieved the prestigious accomplishment of giving the State of the Art …
We’re thrilled to announce that our article, “Building trust and inclusion with under-served groups: a public involvement project employing a knowledge mobilisation approach,” …
Antimicrobials have revolutionised medicine, saving countless lives by treating infections that were once fatal.
In an exciting development bridging science, art, and public engagement, we have appointed internationally acclaimed BioArtist Anna Dumitriu as our new Artist in Residence for the 2023–2028 funding cycle.
Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests.
Professor Del Galdo, Workstream 3 lead for Musculoskeletal Disease at Leeds Biomedical Research Centre (BRC), has collaborated with experts across Europe and the Middle East to establish comprehensive, evidence-based guidance for the treatment and management of systemic sclerosis (SSc).
The NIHR Leeds Biomedical Research Centre Patient and Public involvement team trialled a new style of event in partnership with Better Leeds Communities at Burley lodge to help introduce people to the world of health research.
On 31 October and 1 November, the NIHR Leeds Biomedical Research Centre (BRC) held its annual away day, bringing together researchers, clinicians, and leaders to strengthen the vision and goals of the Centre.
The NIHR Leeds BRC is delighted to announce that Professor Sinisa Savic has been appointed as our Deputy Director starting 1 November 2024.
The Antimicrobial resistance diagnostics team at the office of the Chief Scientific Officer NHS England hosted its third event in the successful Moving Forwards Infection Diagnostics series, titled “Optimising Evaluations”.